SGLT2 inhibitors and kidney outcomes in the real world
Smith SM
BMJ 2020;369:m1584
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak B, Wintzell V, Melbye M, et al.
BMJ 2020;369:m1186
Leggi
Managing new-onset type 1 diabetes during the COVID-19 pandemic: challenges and opportunities
Garg SK, Rodbard D, Hirsch IB, Forlenza GP
Diabetes Technol Ther. Pub. online 17 April 2020
Leggi
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
Ehrmann D, Kulzer B, Roos T, et al.
Lancet Diabet Endocrinol. 2020;8(5):436-46
Leggi
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
Ghosh-Swaby OR, Goodman SG, Leiter LA, et al.
Lancet Diabet Endocrinol. 2020;8(5):418-35
Leggi
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Yabe D, Nakamura J, Kaneto H, et al.
Lancet Diabet Endocrinol. 2020;8(5):392-406
Leggi
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
Yamada Y, Katagiri H, Hamamoto Y, et al.
Lancet Diabet Endocrinol. 2020;8(5):377-91
Leggi
The association of ambient fine particulate matter exposure during pregnancy with blood glucose levels and gestational diabetes mellitus risk: a prospective cohort study in Wuhan, China
Ye B, Zhong C, Li Q, et al.
Am J Epidemiol. Pub. online 14 April 2020
Leggi
Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study
Qiang JK, Sutradhar R, Giannakeas V, et al.
Diabetologia. 2020;63:944-53
Leggi
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study
Jujić A, Atabaki-Pasdar N, Nilsson PM, et al.
Diabetologia. 2020;63:1043-54
Leggi